Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Monday, January 18, 1999 Published at 14:16 GMT


Health

Sperm treatment trial urged

The technique uses sperm before they reach maturity

By BBC Correspondent Matt Youdale

A doctor whose groundbreaking fertility technique is banned in the UK is seeking permission to perform a controlled trial of the method.

He hopes to prove that it is safe to use.

The method, known as the spermatid technique, has produced several pregnancies, but has been banned since it produced its first successful result three years ago.

The Human Fertility and Embryology Authority, which regulates fertility treatments in the UK, is concerned that it could pose health risks.

Dr Simon Fishel, who developed the technique at Nottingham University's Nurture fertility unit, currently has to take patients to Italy if he wants to offer them the treatment.

He said that if the HFEA refuses his application, he will continue to take patients abroad.

Case study


BBC Correspondent Matt Youdale talks to the Oxburghs
Susan Oxburgh is a typical toddler - bouncing with mischief and good health. But the way she was conceived makes her very special indeed.

Her parents Gavin and Jenni had gone to Nottingham for fertility treatment. But when doctors looked for sperm to carry out in-vitro fertilisation, they could not find any. So they used an immature sperm instead.


[ image: The technique has proved successful in some cases]
The technique has proved successful in some cases
The treatment was a success and Susan was conceived.

But almost immediately the HFEA outlawed the treatment, because of doubts about its safety.

The ban is still in force. As a result, Dr Fishel has been taking patients abroad to continue his work. Now he has asked the HFEA for a licence to carry out a controlled trial.

He said: "We have shown that as far as we can tell the genetics of the immature sperm is similar to the mature sperm.

"But in a sense these are all studies outside of the body, in a test tube. The real study is what happens at the end of the day.

"We recognise there's an element of risk, but we also recognise that we're not going to get all the answers without attempting a clinical trial."

Mixed opinions


[ image: Lord Robert Winston:
Lord Robert Winston: "Overwhelming evidence"
Medical opinion about spermatids is mixed. Some scientists believe their use does pose genetic risks. But the momentum for a formal trial is growing.

Among those in favour is one of Britain's best known fertility specialists - Lord Robert Winston, from Hammersmith Hospital in London.

He said: "The evidence now is almost overwhelming that there should be some sort of trial.

"There isn't really any serious evidence that you could safely say that injecting a sperm cell, with the right number of chromosomes, is any more risky than injecting a sperm cell."

Ban in place

But the HFEA still has reservations. Dr Anne McLaren chairs the authority's working group on new developments in reproductive technology.

She said: "So far we're not satisfied that our concerns can be ignored.

"We were given the task by Parliament of being, as it were, a watchdog and also the responsibility of looking after, as far as we can, the welfare of the child."

The authority will consider the application in the coming weeks. If it is turned down, Dr Fishel says he'll continue to offer the spermatid treatment in Italy - where it can cost British patients up to £10,000 a time.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

13 Jan 99†|†Health
Natural pregnancies for 'infertile' couples

15 Dec 98†|†Health
Modern fertility techniques boost success rates

15 Dec 98†|†Health
Controversy over fertility wonder technique





In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99